2-FLUORO-6-METHYLBENZONITRILE

We are 2-FLUORO-6-METHYLBENZONITRILE CAS:198633-76-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-FLUORO-6-METHYLBENZONITRILE
CAS.NO:198633-76-0
Synonyms:6-Fluoro-o-tolunitrile;
2-Fluoro-6-Methylbenzonitrile; 
2-Cyano-3-fluorotoluene
Molecular Formula:C8H6FN
Molecular Weight:135.13800
 
Physical and Chemical Properties:
Density:1.11;
Melting point:39-46oC;
Boiling point:207.4.oC;
Flash point:91oC;
Index of Refraction:1.507;
 
Specification:
Appearance:White powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis

2-FLUORO-6-METHYLBENZONITRILE


Related News: At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate CAS:160969-03-9 Retrogenix’s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses.5-yodouridina CAS:1024-99-3 Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.4-Biphenylboronic acid Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.“CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.

Related Products
Product Name
5-[1-hydroxy-2-(2,4,5-trifluorophenyl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione View Details
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride View Details
6-Chloropyridazin-3-amine View Details
3-Iodotoluene manufacturer Cyclopropanesulfonyl chloride manufacturer Indolo[2,3-a]carbazole manufacturer 2-Bromo-5-chlorophenol manufacturer 10-Chloro-1-Decanol manufacturer